You are here

Article Text

Article menu
Download PDFPDF
Editorial commentary
Is old age really a reason to withhold thrombolytic therapy?

https://doi.org/10.1136/jnnp.2005.080192

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Dr Schellinger has received consulting fees and honoraria for presentations from Boehringer Ingelheim, Ingelheim am Rhein, Germany, the manufacturer of Actilyse (rt-PA)

    Linked Articles